about
Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHow do Zimbabweans value health states?Re-scaling social preference data: implications for modelling.Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.Estimating Domestic Values for EQ-5D Health States Using Survey Data From External Sources.Development of the EQ-5D-Y: a child-friendly version of the EQ-5DFeasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study.Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.Results from an exploratory study to test the performance of EQ-5D-3L valuation subsets based on orthogonal designs, and an investigation into some modeling and transformation alternatives for the utility function.Can adult weights be used to value child health states? Testing the influence of perspective in valuing EQ-5D-Y.From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmakingGrowth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysisUS norms for six generic health-related quality-of-life indexes from the National Health Measurement study.Toward a consensus on the QALY.Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.Toward Explicit Prioritization for the Caribbean: An EQ-5D Value Set for Trinidad and Tobago.Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008.What matters most? Evidence-based findings of health dimensions affecting the societal preferences for EQ-5D health states.EQ-5D-3L as a health measure of Brazilian adult population.Logical Inconsistencies in 3 Preference Elicitation Methods for EQ-5D Health States: A Study in the Brazilian Population.The effect of health state selection on the valuation of EQ-5D.Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers.Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets.Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies.Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.Size matters: EQ-5D in transition.Valuations of EQ-5D health states: are the United States and United Kingdom different?Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs.Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis.Social valuation of EQ-5D health states: the Chilean case.Measuring population health: a comparison of three generic health status measures.Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?Using standardised measures of health-related quality of life: critical issues for users and developers.Societal Preferences for EQ-5D Health States from a Brazilian Population Survey.Cost-effectiveness analysis: a view into the abyss.Long-term quality of life in trauma patients following the full spectrum of tibial injury (fasciotomy, closed fracture, grade IIIB/IIIC open fracture and amputation).
P50
Q24802062-D02397EB-7817-4653-81F6-6EF1CA0C2ACFQ24806895-DFD030FD-A169-4779-AB51-764FE2778A0CQ30984523-0D0BBE14-9E3F-4D8C-BFA7-0DF6F6E71780Q30997797-899AEC0C-17A4-4CD7-B536-30199254A5C4Q31000138-110361C8-F365-4AD1-B911-A120F137FBDCQ33402883-9BD34B96-A166-43E7-B292-977BC86812A3Q33942861-8F06B68D-3F9A-484B-9D17-05115C91CF35Q33942875-6ABF5C93-4765-46B3-A447-3D2C633A7956Q34292493-EF582673-CD6A-4E7F-A506-6B9E04BE5645Q34641292-7E1EDEBF-1A9C-40F4-8C64-C0E4E0893869Q35148263-34AF717B-6609-49B9-87B2-727A2E8D44C7Q35851066-5BCFD839-9D0D-4FF3-808C-92A7236CFC06Q36042973-2F92541E-0DAD-4B33-AEED-5F00E52CF6CCQ36390478-70CC4329-8F6B-4B6D-BED0-467C5EE7D92AQ36432185-092E93A1-AABF-4912-9052-5D91CE41C322Q37109785-20A08323-3C84-46AF-8EE2-D825CC6B3449Q37403584-57B432A2-A9D8-4DDF-AC95-A01738403ECAQ37517368-62AC3DAD-D5D7-4A54-93AE-0FEC903349AAQ39094001-E1F27942-DD85-480A-9663-33BFD8D81B44Q39971781-6713FD92-3D5B-4122-AE6E-43D4E5819D00Q40235378-F2490903-F628-4A60-A6F8-B2FEC7FF267BQ40274278-8325AE39-C836-47A0-A5A1-AADC86DE4693Q40306709-B9EEA2E8-08FA-4581-90C0-201D70ACD813Q42670136-D750E417-C043-4199-A2A4-C9A0AEF72312Q44234115-90436DE7-D044-4D26-9E72-D8921D86E962Q44887076-151C5C8D-717E-47B1-BA7E-0583338DDE67Q45836329-DD8A52DC-19D5-414D-B220-76398374B8FAQ47272113-1C90BF45-4C78-4D64-9C3C-0E072527309FQ47273522-F7EEEA36-475A-4981-BF5F-C9443137F0FFQ47290767-3DDD6BFD-C963-4A1F-BD69-27869D279C17Q47685599-6E82F7C8-48AD-4696-9FEB-917FE7BAF50DQ47806198-78AB860B-7369-4A8C-9180-93EC83DBC9EAQ48054323-B63CEC85-1456-430D-BD74-A1F72FBAE153Q48524423-694B41C9-0579-41F2-AF61-822F03BE8E60Q50484938-388AEEBE-CAF3-4B41-A5CE-B5EA4E75C6A1Q51981551-22FCC968-D223-4B6E-8940-80C881A6D648Q52009208-4A168801-B9F1-40C3-8DAE-6DCFD0997270Q52801550-02A2847B-984E-4638-9874-F714AC6C6F7FQ52838616-E54DB520-33FA-404B-AFA5-498E39A5CFE4Q52850395-39FA43F3-6165-4323-A1F3-2F0599A88B66
P50
description
hulumtues
@sq
researcher
@en
researcher
@en-gb
wetenschapper
@nl
հետազոտող
@hy
name
Paul Kind
@ast
Paul Kind
@en
Paul Kind
@en-gb
Paul Kind
@es
Paul Kind
@nl
Paul Kind
@sl
type
label
Paul Kind
@ast
Paul Kind
@en
Paul Kind
@en-gb
Paul Kind
@es
Paul Kind
@nl
Paul Kind
@sl
prefLabel
Paul Kind
@ast
Paul Kind
@en
Paul Kind
@en-gb
Paul Kind
@es
Paul Kind
@nl
Paul Kind
@sl
P106
P1153
55618233100
P2031
1978-01-01T00:00:00Z
P21
P31
P496
0000-0003-2377-1652